ALCOX:EPA
NicOx SA
€0,31
arrow_downward
-1,57%(-0,0050) 1D
7 ຕ.ລ., 17 ໂມງ 35 ນາທີ 23 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0,32
High
€0,32
Low
€0,31
Mkt. cap
30,90 ລ້ານ
Avg. vol.
167,87 ພັນ
Volume
223,49 ພັນ
52-wk high
€0,57
52-wk low
€0,28
EPS
€-0,03
Shares outstanding
97,55 ລ້ານ
No. of employees
10
Open
€0,32
High
€0,32
Low
€0,31
Mkt. cap
30,90 ລ້ານ
Avg. vol.
167,87 ພັນ
Volume
223,49 ພັນ
52-wk high
€0,57
52-wk low
€0,28
EPS
€-0,03
Shares outstanding
97,55 ລ້ານ
No. of employees
10
News stories
From web sources and news partners
Carroll County Mirror-Democrat
·
47 ນາທີກ່ອນ
APA Corporation provides third-quarter 2026 supplemental information and schedules results conference call for Nov. 5 at 10 a.m. Central time
Stock Titan
·
39 ນາທີກ່ອນ
Nasdaq grants Murano Global (Nasdaq: MRNO) more time to meet its $1 bid-price rule.
FinancialContent
·
18 ນາທີກ່ອນ
Applied Digital (NASDAQ:APLD) Beats Expectations in Strong Q3 CY2026
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, ຝຣັ່ງ
SectorBiotechnology
Websitenicox.com